Cited 0 times in Scipus Cited Count

Parotid gland as a risk organ in whole brain radiotherapy.

DC Field Value Language
dc.contributor.authorNoh, OK-
dc.contributor.authorChun, M-
dc.contributor.authorNam, SS-
dc.contributor.authorJang, H-
dc.contributor.authorJo, S-
dc.contributor.authorOh, YT-
dc.contributor.authorLim, JC-
dc.date.accessioned2012-05-03T01:10:06Z-
dc.date.available2012-05-03T01:10:06Z-
dc.date.issued2011-
dc.identifier.issn0167-8140-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/6713-
dc.description.abstractBACKGROUND AND PURPOSE: Since the introduction of CT-based simulation for use in whole brain radiotherapy (WBRT), we have observed that a large volume of the parotid glands is included in the radiation fields. The purpose of this study is to analyze the dose-volume statistics of the parotid glands in patients undergoing WBRT.



MATERIALS AND METHODS: Thirty-two patients received WBRT using CT-based simulation with bilateral two-field arrangement. Daily fraction was 3 Gy with total dose of 30 Gy in 2 weeks. We analyzed the radiation dose from WBRT to the parotid glands.



RESULTS: Average of the mean parotid dose was 17.5 Gy (range, 10.5-26.2) for both glands. Mean parotid doses ≥20 and ≥25 Gy were observed in 22 (34.4%) and 4 (6.3%) of 64 individual glands. The numbers of patients with a mean parotid dose of both glands ≥20Gy and ≥25 Gy were 12 (37.5%) and 1 (3.1%), respectively.



CONCLUSIONS: Mean parotid dose was variable in patients with WBRT. According to the parotid dose and combined potential risk factors, parotid glands can be regarded as a risk organ in WBRT for improvement of patient quality of life.
-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHBrain Neoplasms-
dc.subject.MESHCranial Irradiation-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHParotid Gland-
dc.subject.MESHRadiation Dosage-
dc.subject.MESHRisk-
dc.titleParotid gland as a risk organ in whole brain radiotherapy.-
dc.typeArticle-
dc.identifier.pmid21300416-
dc.identifier.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0167-8140(11)00007-7-
dc.contributor.affiliatedAuthor노, 오규-
dc.contributor.affiliatedAuthor전, 미선-
dc.contributor.affiliatedAuthor오, 영택-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/j.radonc.2010.12.013-
dc.citation.titleRadiotherapy and oncology-
dc.citation.volume98-
dc.citation.number2-
dc.citation.date2011-
dc.citation.startPage223-
dc.citation.endPage226-
dc.identifier.bibliographicCitationRadiotherapy and oncology, 98(2). : 223-226, 2011-
dc.identifier.eissn1879-0887-
dc.relation.journalidJ001678140-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Radiation Oncology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse